Vontobel Financial Products GmbH (F38525)

So what’s Advent doing with 85 employees and about $30M in revenues back in 2024? Plus they have the business and Cognate / River to hold their hand. My belief is they already pivoted as you can see by Advent’s website.

I didn't feel that I needed to answer, but
if the MHRA or FDA issues a definitive rejection or demands a completely new Phase III trial, due to the trial's controversial external-control design, NWBO's valuation will face an existential threat.
Without DCVax-L approval, they would b

I hope I can still spin my head at old age !! Cant wait forever 😜

If you were at all paying attention my stance has always been to get off your sheepish butts before it’s too late to 1) force new management 2) claw back Advent 3) get the CDMO up and running! Somehow 2 was achieved but sneakily without the revenues, sadly.

Wouldn't ADVENT be a wholly owned subsidiary?

Yes it does but those holding through the Jan 5 ex date and then sold will most likely get it too. This company is doing things right 

https://www.patreon.com/posts/163510848

Impressions on The CHMP Blarcamesine Rejection Justification"

Upbeat re-visit of the CHMP conclusion by Bio_Oko. Basically, he observes that Anavex was trying to get those folks to see the goodness in the numbers, hoping they'd i

Yeah forgot about this one. Bigtime scam in the past. They used to advertise on iHub. Really good share structure. Will check it out. They put it in the time capsule in 2023. Someone gotta open it up some day

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

As usual, you are wrong.

I never said I was an "expert" on DBMM's financial reports. I said I had forecast DBMM's revenues pretty accurately. And my past posts about them have been proven to be just that.

Where did I say I was an "expert"? Sounds like your opinion a

$.17 is proof that the drug has not been approved in 923 days.

The jury i.e. MHRA is still out on whether the drug works or not.

Any other conclusion is based on wishful thinking.

Yep and let's see what happens going forward giving the current state of affairs. Maybe a pendulum or whiplash experience may be next up giving patterns of history. 

Thanks for all the hard work, SSKILLZ. Should be an interesting contest. I'll be interested to see how the indices fare. We will find out if our collective stock-picking ability paints us as contenders or pretenders!

Recent Trades -
Time ET Ex Price Change Volume
15:36:59 Q 0.0071 0.0008 200,000
15:30:40 Q 0.0071 0.0008 13,579
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
1

The reason it’s taken so long is BIOAQ had to wait until CERN was shut down to close off the parallel universe and enable the completion of the merger. Duh!

Is this going lower or is it time to buy?

70 out here at the foot of the mountain

Company is broke.

And I think I can fairly assume you would be willing to add that we longs are about to languish in more silence...waiting on certain death.

So why all the effort if we're really about to get our comeuppance as a result of the ill behavior you attrib

NVOS TOI

AITX PZZA INBS

MAXN VATE STAL

IBLR HOLO GFAI COSM

Maybe that means we get the dividend on the share amounts we have now not on Jan 5th.. I have more shares now than Jane 5th, for sure.

NHMD TWOH GSPT